End-of-life care issues

Failure to diagnose dying is the commonest single failure in end-of-life care. Unless the possibility is actively considered, dying patients continue to receive resuscitation, futile investigations and transfer out of their homes to hospital for their last hours and days.

Use the Gold Standards Framework triggers: the "surprise" question, patient choice or need for comfort care only, and clinical indicators of advanced disease.

Prognostic uncertainty is unavoidable. Use ePrognosis, Palliative Performance Scale, Karnofsky and ECOG with clinical experience, and communicate in terms of time, function or unpredictability, always as ranges.

Non-cancer trajectories are far less predictable than cancer. Patients with organ failure, frailty and dementia deteriorate in a stuttering, unpredictable way and are therefore systematically under-referred to palliative services.

Goals-of-care conversations occur far too infrequently and far too late. Barriers cited by clinicians: uncertainty about prognosis, fear of provoking distress, and fear of jeopardising a long-standing relationship. The evidence is the opposite of the fear — serious illness conversations reduce patient anxiety and depression and do not harm the doctor–patient relationship.

Structured frameworks help: REMAP, the Serious Illness Conversation Guide, and the five-step approach — (i) initiate the discussion, (ii) clarify the prognosis, (iii) evaluate the patient and family, (iv) identify end-of-life goals, (v) develop a plan of care.

Never say "there is nothing more we can do." Reframe the discussion around what will be provided — analgesia, positioning, non-drug comfort measures, presence.

Do not shift the decisional burden onto relatives. If families are given the (incorrect) impression that the decision to withhold or withdraw treatment is theirs to make, they suffer significant and lasting distress from the emotional burden, even when consensus is reached. The decision is a clinical recommendation made in the patient's best interests, shared with and explained to the family.

The four principles — autonomy, beneficence, non-maleficence and justice — are frequently in conflict at the end of life.

Withholding and withdrawing an ineffective or unduly burdensome treatment are morally and legally equivalent. This permits a time-limited trial, and it must be explained that death results from the underlying disease, not the withdrawal.

Futility — clinicians are ethically empowered to decline care that is medically futile, but the futility principle is itself contested. Where clinician and patient or proxy disagree, options include transfer to another clinician, the institutional ethics committee, social services, or patient-advocacy agencies.

Palliative sedation versus euthanasia — sedation is titrated to the symptom with regular review, and death results from disease. Administering high doses by continuous infusion without titration and without considering hydration implies a different intent.

Assisted dying — assisted suicide = supplying the means; euthanasia = administering the lethal drug. Arguments for: autonomy, existential distress, futility. Arguments against: coercion of the vulnerable, absence of watertight safeguards, imprecision of prognosis. Three of 18 Oregon patients given lethal prescriptions had unrecognised, untreated depression; internal coercion ("I have a duty to die") is very difficult to detect. When a patient asks, first explore what they are actually asking. RATIONING AND AGEISM — A HIGH-YIELD ETHICAL POINT EXAMINERS LIKE Older adults are prime targets for rationing because they consume disproportionate resources and are seen as having "already lived their lives". Outcome measures based on quality-adjusted life-years or active life expectancy are inherently biased against the elderly, and treating dependency as the primary outcome implies that disability is equivalent to death. Geriatricians must be vigilant advocates against this.

Advance care planning and advance directives (ACD) — an advance decision to refuse treatment (living will) is binding where it is specific to the situation, made with capacity, voluntary, informed, and not subsequently invalidated. It takes effect only once capacity is lost. Review yearly, on deterioration, and before care-home admission. Values rarely change over a lifetime; care decisions can.

Surrogate decision-making — a durable power of attorney for health care or proxy covers situations a living will cannot (for example, whether an antibiotic is life-supporting or comfort care). Where none exists, the best-interests standard and, if necessary, court-appointed guardianship apply.

POLST / MOLST (Physician or Medical Orders for Life-Sustaining Treatment) convert the patient's advance directive into an actionable, transferable medical order valid across settings. Especially critical for those who want to avoid some or all life-sustaining treatment, reside in or need long-term care, or might die within the next year.

Legislation alone changes little. The US Patient Self-Determination Act (1991) requires institutions to inform patients of their rights to participate in decisions, accept or refuse treatment and prepare an advance directive — but does not require an advance directive to be made, and has had minimal impact on completion rates. Hence the shift toward POLST/MOLST and electronic records that travel with the patient. SEVEN LEGAL MYTHS THAT OBSTRUCT GOOD END-OF-LIFE CARE (ACP/ASIM) — ALL FALSE

Forgoing life-sustaining treatment in an incapacitated patient requires proof of their actual wish 2. Withholding or withdrawing artificial fluids and nutrition is illegal

Risk management must be consulted before stopping life-sustaining treatment

Advance directives must use specific forms, are not transferable between states, and oral directives are unenforceable

A doctor giving high-dose analgesia that results in death will be prosecuted

When suffering is overwhelming despite palliative care, no legally permissible options exist 7. The 1997 US Supreme Court decisions outlawed physician-assisted suicide

DNACPR — two separate questions: (i) can CPR work physiologically? (a clinical judgement — in advanced terminal disease the chance is markedly reduced, and in one series no terminally ill patient survived); (ii) is the resulting quality of life worth having? (only the patient can answer). A discussion that implies a genuine choice where CPR is futile is misleading. Public expectations are distorted by television dramas that grossly overstate success.

Symptom burden — pain, breathlessness, nausea and vomiting, constipation, terminal agitation and delirium, and respiratory secretions. Requires anticipatory prescribing, a subcutaneous route established before swallowing fails, deprescribing of burdensome drugs, and meticulous comfort care (mouth, pressure areas, bowel and bladder). Watch iatrogenic harm from the very drugs used — opioids, steroids, anticholinergics, metoclopramide and haloperidol.

Nutrition and hydration must be considered separately. Hydration is a comfort measure and adjunct to mouth care — subcutaneous hypodermoclysis is simple, very low-risk, as effective as IV for maintenance, and grossly under-used; avoid fluid overload. Nutrition is emotionally charged: exclude reversible causes of anorexia (hypercalcaemia, hyperglycaemia, renal failure, infection); corticosteroids give only a short-lived appetite effect at significant cost, megestrol has no advantage, and artificial nutrition rarely improves survival or quality of life while nasogastric feeding is uncomfortable and risks aspiration.

Preferred place of death is often not achieved — 49–100% of cancer patients wish to die at home, yet only about 26% of cancer deaths and 20% of all deaths occur there. Where preference had been documented, place of death matched it in 73%. Arrange beds, oxygen, commodes, drugs, a named prescriber and carers before discharge.

Care homes — there is a strong case for collaborative future care planning for every resident. Residents are by definition frail with significant disease burden and often cognitive impairment; on deterioration, hospital admission offers minimal gain in length or quality of life with substantial harm and risk, and carries an opportunity cost for other patients. Document which interventions are not to be used (hospital admission, CPR, ventilation, artificial nutrition in advanced dementia) while retaining those that remain appropriate (for example, antibiotics for a urinary infection).

Care pathways — the Liverpool Care Pathway improved symptom control, communication with relatives and nurses' confidence, but was withdrawn in the UK after complaints; the fault lay in "tick-box" application, not the pathway concept. It was replaced by the Five Priorities for Care of the Dying Person and personalised plans. If the patient improves, stop the pathway, reassess and reconsider active treatment.

Culture defines how patients and families understand illness, suffering and dying — including how pain is experienced and expressed. Use of life-prolonging technology, the locus of decision-making, and truth-telling are all culturally shaped. Where adult children ask that a diagnosis be withheld, the practical solution is to ask the patient whether they are the kind of person who wants all the details, or would prefer a family member to handle the decisions — this respects culture without assuming the patient conforms to it. Practise cultural humility, acknowledging one's own unrecognised biases.

Spiritual concerns must be addressed explicitly, not dismissed. Where a family holds a strong belief in a miraculous cure, a chaplain can explore it and negotiate a plan that is respectful of the belief yet realistic — for example, that forgoing further chemotherapy does not change whether a miracle is possible.

Informal caregivers deliver most end-of-life care with very limited resources, and caregivers reporting emotional stress have significantly increased mortality. Grief begins at diagnosis, not at death. Warning signs of complicated grief: sudden or traumatic death, loss of a child, and an ambivalent relationship. Bereaved relatives have increased depression, cardiac events, intercurrent infection and mortality; hospices provide bereavement follow-up for about one year. Offer families Byock's "Five Things".

The revised EAPC framework on palliative sedation (Palliative Medicine, 2024), an international Delphi consensus of 42 statements, reframes practice: proportionality is built into the definition; "suffering" now explicitly includes physical, psychological and existential distress; "refractory" means untreatable (clinician view) and intolerable (patient view); no fixed remaining life expectancy is set as a criterion; hydration is decided independently of sedation; and patient autonomy is strongly emphasised, with a stepwise pharmacological approach.

NICE guidance (NG31, quality standard QS144) states clearly that there is no evidence that clinically assisted hydration prolongs dying, nor that withholding it hastens death. Practice: assess hydration daily, support safe oral intake, consider a therapeutic trial with monitoring at least 12-hourly, continue if benefit, and reduce or stop if harm or if the patient no longer wants it. "One-size-fits-all" prescribing proformas are explicitly discouraged.

Systematic reviews and meta-reviews (2023–2025) show ACP reliably improves process outcomes — documentation, patient and surrogate engagement, and concordance between stated preferences and delivered care — but has limited or inconsistent effect on hospitalisation, health status and survival.

The field has consequently shifted from "completing a document" to iterative goals-of-care communication, surrogate preparation and system-level implementation.

Supreme Court of India, 24 January 2023 (Common Cause v Union of India) simplified the 2018 framework: the advance medical directive no longer requires a Judicial Magistrate's countersignature — a notary or gazetted officer suffices; more than one guardian may be named; approval runs through a Primary Medical Board and a Secondary Medical Board with defined 48-hour timelines; courts intervene only in disputes.

The ISCCM–IAPC Expert Consensus and Position Statement for End-of-Life and Palliative Care in the ICU (Indian Journal of Critical Care Medicine, 2024) is now the operative Indian bedside document, providing a structured process for foregoing life-sustaining treatment (FLST) based on physician prognostic assessment, documented shared decision-making, due process consistent with the 2023 Supreme Court safeguards, and integration of palliative care into the ICU.

The MoHFW draft guidelines for withdrawal of life support in terminally ill patients (September 2024) operationalise the 2018 and 2023 orders, defining terminal illness and the two-tier medical board pathway. Assisted dying — the international legal landscape is moving fast

In England and Wales, the Terminally Ill Adults (End of Life) Bill — which would have permitted assisted dying for mentally competent adults with a prognosis under six months — passed the House of Commons on 20 June 2025 (314 to 291) but fell on 24 April 2026 after more than 1,200 amendments stalled it in the House of Lords and the session was prorogued. A successor bill was reintroduced in the Commons on 17 June 2026, with second reading scheduled for 11 September 2026.

Jersey passed its Assisted Dying Law on 26 February 2026 — eligibility requires terminal illness with unbearable physical suffering and expected death within 6 months (12 months for neurodegenerative disease such as Parkinson's or motor neurone disease), assessment by two independent doctors, and — uniquely among jurisdictions — permits a doctor or nurse to administer the substance. A separate assisted dying bill is before the Scottish Parliament.

India's position is unchanged: passive euthanasia and withdrawal of life support are lawful under the Supreme Court framework; active euthanasia and assisted suicide remain illegal.

Indian access data (2025): 7–10 million people need palliative care annually and fewer than 4% receive it; 44.5% of all centres are in Kerala; morphine is stocked in only about 66% of centres; median travel time to the nearest centre is 118 minutes; and no Indian national or state essential medicines list contains all recommended morphine formulations.